IS6589A - Lyfjablanda úr bíkalútamíði og tamoxífeni til að framkalla and-andrógenísk áhrif og and-estrógenískáhrif - Google Patents

Lyfjablanda úr bíkalútamíði og tamoxífeni til að framkalla and-andrógenísk áhrif og and-estrógenískáhrif

Info

Publication number
IS6589A
IS6589A IS6589A IS6589A IS6589A IS 6589 A IS6589 A IS 6589A IS 6589 A IS6589 A IS 6589A IS 6589 A IS6589 A IS 6589A IS 6589 A IS6589 A IS 6589A
Authority
IS
Iceland
Prior art keywords
androgenic
bicalutamide
tamoxifen
pharmaceutical preparations
estrogenic effects
Prior art date
Application number
IS6589A
Other languages
English (en)
Inventor
Furr Barrington
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6589A publication Critical patent/IS6589A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS6589A 2000-05-23 2002-10-25 Lyfjablanda úr bíkalútamíði og tamoxífeni til að framkalla and-andrógenísk áhrif og and-estrógenískáhrif IS6589A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012291.1A GB0012291D0 (en) 2000-05-23 2000-05-23 Pharmaceutical combination
PCT/SE2001/001162 WO2001089515A1 (en) 2000-05-23 2001-05-22 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect

Publications (1)

Publication Number Publication Date
IS6589A true IS6589A (is) 2002-10-25

Family

ID=9892038

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6589A IS6589A (is) 2000-05-23 2002-10-25 Lyfjablanda úr bíkalútamíði og tamoxífeni til að framkalla and-andrógenísk áhrif og and-estrógenískáhrif

Country Status (23)

Country Link
US (1) US20030134899A1 (is)
EP (1) EP1292296A1 (is)
JP (1) JP2003534278A (is)
KR (1) KR20030001535A (is)
CN (1) CN1431899A (is)
AU (1) AU2001262833A1 (is)
BR (1) BR0111051A (is)
CA (1) CA2407028A1 (is)
CZ (1) CZ20023785A3 (is)
EE (1) EE200200654A (is)
GB (1) GB0012291D0 (is)
HK (1) HK1053061A1 (is)
HU (1) HUP0302276A3 (is)
IL (1) IL152545A0 (is)
IS (1) IS6589A (is)
MX (1) MXPA02011472A (is)
NO (1) NO20025638L (is)
NZ (1) NZ521979A (is)
PL (1) PL363504A1 (is)
RU (1) RU2002134483A (is)
SK (1) SK16562002A3 (is)
WO (1) WO2001089515A1 (is)
ZA (1) ZA200208845B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
DK1460969T3 (da) * 2001-11-29 2008-09-01 Gtx Inc Forebyggelse og behandling af ved androgen-berövelse fremkaldt osteoporose
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
GB0424339D0 (en) * 2004-11-03 2004-12-08 Astrazeneca Ab Combination therapy
JP2008534575A (ja) * 2005-03-29 2008-08-28 ユーエスヴィー リミテッド ビカルタミドの調製のための新規プロセス
CN114748480B (zh) * 2021-01-08 2023-10-20 轩竹生物科技股份有限公司 一种预防和/或治疗癌症的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (is) * 1962-09-13
EP0100172B1 (en) * 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex

Also Published As

Publication number Publication date
NZ521979A (en) 2004-06-25
IL152545A0 (en) 2003-05-29
GB0012291D0 (en) 2000-07-12
CA2407028A1 (en) 2001-11-29
EE200200654A (et) 2004-06-15
WO2001089515A1 (en) 2001-11-29
SK16562002A3 (sk) 2003-05-02
PL363504A1 (en) 2004-11-29
HUP0302276A2 (hu) 2003-11-28
AU2001262833A1 (en) 2001-12-03
RU2002134483A (ru) 2004-06-27
ZA200208845B (en) 2004-02-27
EP1292296A1 (en) 2003-03-19
MXPA02011472A (es) 2004-09-06
HK1053061A1 (zh) 2003-10-10
KR20030001535A (ko) 2003-01-06
CN1431899A (zh) 2003-07-23
HUP0302276A3 (en) 2005-06-28
NO20025638D0 (no) 2002-11-22
JP2003534278A (ja) 2003-11-18
US20030134899A1 (en) 2003-07-17
CZ20023785A3 (cs) 2003-03-12
BR0111051A (pt) 2003-04-15
NO20025638L (no) 2002-11-22

Similar Documents

Publication Publication Date Title
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20071303L (no) Farmasoytiske preparater
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
NO20033556D0 (no) Farmasöytiske preparater
AR028387A1 (es) Forcps quirurgico miniaturizado y metodos para su produccion
DK1283713T3 (da) Kombinerede brusk- og planteekstraktpræparater
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
DK1181397T3 (da) Rhodium-elektrokatalysator og fremgangsmåde til fremstilling af denne
DK1615622T3 (da) Doxycyclinpræparater til indgivelse én gang dagligt
IS6589A (is) Lyfjablanda úr bíkalútamíði og tamoxífeni til að framkalla and-andrógenísk áhrif og and-estrógenískáhrif
NO20004907D0 (no) Vandig emulsjon og fremstilling derav
EE200200626A (et) Antraniilamiidid ja nende kasutamine ravimitena
EE200200393A (et) Glüburiidi ravimkoostis
NO20041058L (no) Preparater og fremgangsmater relatert til nye benzodiazepinforbindelser og mal derav
NO20025158L (no) Lipidpreparat og anvendelse derav
NO20031532D0 (no) Pravastatinnatrium, hovedsakelig fri for pravastatinlacton og epi-pravastatin, og preparater inneholdende dette
DK1311731T3 (da) Fremgangsmåde og arrangement til stolpesystem
NO20021949L (no) Nye hormonpreparater og anvendelse av dem
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
FI20001477A0 (fi) Influenssavirusta sitova aine ja sen käyttö
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
NO20031537L (no) Nye farmasöytiske blandinger inneholdende epinastin og pseudoefedrin